Evaluation of moxibustion therapy for urge urinary incontinence after stroke

Completed

• Conditions: rge urinary incontinence after stroke; Urological and Genital Diseases; Other specified urinary incontinence

• Registration Number: ISRCTN44706974
• Lead Sponsor: Project for national clinical research bases construction of State Administration of TCM (China)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-12-31
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

1. Male or female, age between 40 and 75 years
2. In-patients with urge urinary incontinence after stroke, according to the diagnosis criteria of the American Stroke Association (ASA) and the International Continence Society (ICS)
3. 4th to 48th week after stroke onset
4. Urge urinary incontinence occurring after stroke onset, or obvious urgent or frequent micturition instead of urinary incontinence
5. Normal consciousness, communication ability and recognition
6. Provided written informed consent

Exclusion Criteria

1. Insufficiency of heart, liver, kidney or other important organs
2. Chronic urinary retention or urinary incontinence before stroke
3. Urge urinary incontinence caused by spinal injury or other diseases
4. Stress urinary incontinence or chronic urinary tract infection
5. Obvious urgent or frequent micturition pre-stroke, due to hyperplasia of prostate gland

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The mean volume of each micturition will be assessed at the baseline and at the end of the 4th and the 16th week after randomization

Secondary Outcome Measures

Name	Time	Method
1. The average daily frequency of urination<br>2. The number of toilet visits at night<br>3. Quality of life assessment measured by completion of the Incontinence Quality of Life Questionnaire (I-QOL) Chinese version and the Batherl Index (BI) Chinese version<br><br>The secondary outcome measures above will be assessed at baseline and at the end of the 4th and the 16th week after randomization